Results 201 to 210 of about 134,057 (375)

Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage‐Stratified Analysis

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 241-250, January 2026.
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka, Masaki Ueno, Hiroji Shinkawa, Yusuke Yamamoto, Masahiko Kinoshita, Koji Komeda, Tsukasa Aihara, Satoshi Yasuda, Haruki Mori, Masaki Kaibori   +9 more
wiley   +1 more source

Consecutive disruption of intrahepatic bile ducts after ABO-incompatible living-donor re-liver transplantation: A case report. [PDF]

Int J Surg Case Rep
Soyama A, Askeyev B, Hara T, Matsushima H, Adachi T, Eguchi S.   +5 more
europepmc   +1 more source

Ileal bile acid transporter inhibitors in Alagille syndrome and Progressive Familial Intrahepatic Cholestasis: A systematic review into dose–response

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 119-135, January 2026.
Ileal bile acid transporter inhibitors (IBATi), including maralixibat and odevixibat, are a novel approach to the treatment of paediatric cholestatic liver diseases, such as Alagille syndrome (ALGS) and different forms of progressive familial intrahepatic cholestasis (PFIC).
Alise D. E. de Groot, Cristina Chiadò, Jos G. W. Kosterink, Willem S. Lexmond, Paola Mian, Henkjan J. Verkade   +5 more
wiley   +1 more source

A Rare Congenital Disorder of Intrahepatic Bile Ducts. [PDF]

J Clin Exp Hepatol, 2016
Narayanasamy K, Mohan J, Sivanesan K, Babu S, Kumar P, Rajendran K.   +5 more
europepmc   +1 more source

The Influencing Factors of Timing Selection and Effect of Surgical Treatment for Recurrent Intrahepatic Bile Duct Stones

Tiefeng Xu
openalex   +1 more source

The Effects of Bone‐Remodeling Therapy on Survival, Pain, and Skeletal Related Events in the Setting of Renal Cell Carcinoma With Bone Metastases: A Multicenter Investigation From a Large Global Health Research Network (TriNetX)

Cancer Medicine, Volume 15, Issue 1, January 2026.
In this retrospective population study containing 139,859 patients, subjects receiving RANK‐ligand inhibitors had improved survival and decreased rates of skeletal‐related events relative to the overall cohort of patients with metastatic bone lesions.
Brian H. Im, Kevin K. Zarrabi, Aaron R. Hochberg, Mihir S. Shah, James R. Mark, Joseph K. Izes, Patrick T. Gomella, Costas D. Lallas, Leonard G. Gomella, Adam R. Metwalli   +9 more
wiley   +1 more source

Smoking, Alcohol Consumption, and Risks for Biliary Tract Cancer and Intrahepatic Bile Duct Cancer

, 2018
Takeshi Makiuchi, Tomotaka Sobue, Tetsuhisa Kitamura, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Manami Inoue, Shoichiro Tsugane   +8 more
openalex   +2 more sources

Percutaneous Drainage of a Post‐ERCP Liver Abscess: Successful Management of a Rare Complication—A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is an established treatment for choledocholithiasis but may rarely lead to pyogenic liver abscess (PLA). We report the case of a 72‐year‐old woman with a history of biliary stenting who presented with jaundice and cholestasis.
Yavor Asenov, Georgi Jelev, Ivan Vasilev, Boris Kunev, Marin Parunev, Nikolay Penkov, Teophil Sedloev, Ivan Dimitrov   +7 more
wiley   +1 more source

Imaging features of intrahepatic bile duct adenoma in MRI [PDF]

, 2020
Jufeng Qin, Guofeng Zhou, Xiaohui Sheng, Beidi Liu   +3 more
openalex   +1 more source

Embryology of Extra‐ and Intrahepatic Bile Ducts, the Ductal plate

The Anatomical Record, 2008
T. Roskams, Valeer Desmet
semanticscholar   +1 more source